James R. Fricke - Concepedia

Author

James R. Fricke

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

J FRICKE, J Fricke, J. Fricke, J. R. Fricke, J.R. Fricke, JAMES FRICKE, JAMES R. FRICKE, James Fricke, James R Fricke, James R. Fricke

Publications

929

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Pharmaceutical Product Development (United States)Novartis (Switzerland)Novartis (United States)Ortho Clinical Diagnostics (United States)

About

James R. Fricke is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pain research, and pain management.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	602
2	Health Sciences	10	10	493
3	Engineering	2	2	52
4	Business	1	1	37
5	Social Sciences	1	1	29

James R. Fricke

Publications

897

Citations

H-Index

Page 1

	Year	Citations
Etoricoxib in acute pain associated with dental surgery: A randomized, double-blind, placebo- and active comparator-controlled dose-ranging study Kerstin Malmström, Aditi Sapre, Heather Couglin, Clinical Therapeutics Pain TherapyInterventional Pain MedicineHealth SciencesAcute PainPain Medicine	2004	87
A double-blind placebo-controlled comparison of tramadol/acetaminophen and tramadol in patients with postoperative dental pain James R. Fricke, David Hewitt, Donna Jordan, Pain Pain TherapyTramadol 100Acute PainPain MedicineSurgery	2004	86
A double-blind, single-dose comparison of the analgesic efficacy of tramadol/acetaminophen combination tablets, hydrocodone/acetaminophen combination tablets, and placebo after oral surgery James R. Fricke, Rezaul Karim, Donna Jordan, Clinical Therapeutics Single-dose ComparisonHydrocodone/acetaminophen Combination TabletsPain MedicineMedicinePostoperative Pain Management	2002	80
Valdecoxib Is More Efficacious Than Rofecoxib in Relieving Pain Associated With Oral Surgery James R. Fricke, John Varkalis, Sam Zwillich, American Journal of Therapeutics	2002	77
A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: A single-center, randomized, double-blind, placebo- and active-comparator-controlled, parallel-group, single-dose study using the dental impaction pain model Kerstin Malmström, James R. Fricke, Paul Kotey, Clinical Therapeutics Pain TherapyInterventional Pain MedicineHealth SciencesPain MedicineDental Surgery	2002	70
Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental pain David E. Kellstein, D A Ott, S. Jayawardene, International Journal of Clinical Practice Pain TherapyAcute PainPain MedicineLumiracoxib 400Analgesic Efficacy	2004	60
THE OPTIMAL ANALGESIC DOSE OF ROFECOXIB: OVERVIEW OF SIX RANDOMIZED CONTROLLED TRIALS Briggs Morrison, James R. Fricke, J. Brown, The Journal of the American Dental Association Pain TherapyHealth SciencesMedicinePain MedicinePostoperative Pain Management	2000	55
Analgesic efficacy of single oral doses of lumiracoxib and ibuprofen in patients with postoperative dental pain K. Zelenakas, James R. Fricke, S. Jayawardene, International Journal of Clinical Practice	2004	47
MK-966 versus naproxen sodium, 550 MG in post-surgical dental pain James R. Fricke, Barclay Morrison, S FITE, Clinical Pharmacology & Therapeutics Acute PainPain MedicineSurgeryPharmacotherapyPharmacodynamic Modeling	1999	46
Comparison of the Efficacy and Safety of Ketorolac and Meperidine in the Relief of Dental Pain James R. Fricke, Diann Angelocci, Kathleen M. Fox, The Journal of Clinical Pharmacology	1992	45

Page 1